Surv Biopharma

Jordan
Sūf, Jerash, Jordan, 890-8544

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$14.1M
Last funding
Grant / $17.3M / 2025-12-23
Last equity funding
Series B / $14.1M
Investors
15
Lead investors
2
Articles
3

Founders and investors

Lead investors

AMEDKeio Innovation Initiative

Investors

DCI PartnersFFG Venture Business PartnersKeio Innovation InitiativeKyoto University Innovation CapitalNippon Venture Capital